Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors.
about
Screening and identification of genetic loci involved in producing more/denser inclusion bodies in Escherichia coli.A Robust and Efficient Production and Purification Procedure of Recombinant Alzheimers Disease Methionine-Modified Amyloid-β Peptides.Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy.Inclusion bodies: not that bad….Histidine-Rich Oligopeptides To Lessen Copper-Mediated Amyloid-β Toxicity.Modeling amyloids in bacteria.Editorial: Protein Solubility and Aggregation in Bacteria.When amyloids become prionsWhy and how protein aggregation has to be studied in vivo.In vivo amyloid aggregation kinetics tracked by time-lapse confocal microscopy in real-time.Fluorescent dye ProteoStat to detect and discriminate intracellular amyloid-like aggregates in Escherichia coli.Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregationBiomedical Applications of Bacterial Inclusion Bodies
P2860
Q34702799-1AED518A-4C5A-44A7-AD4C-126301E56C8CQ36105742-5CB0EFF8-C0F6-4402-B980-AF05B5647DD5Q38150365-F5D385B8-4EAF-4EAE-B7DB-C8ADAC6EF5BFQ38193089-A70FF3C0-4230-4B49-91AC-EC6B23ABEC43Q38882163-D43C9E9B-25E8-4F5E-86A6-BB6A01C34091Q39494485-DE015655-3239-4B20-948A-B03DF03DBA31Q41936040-C87C3372-FE3A-457D-98E3-29B2F7AC0831Q42215147-20B5F209-AAF4-4A37-B812-96838D1147A7Q43238672-AB36A43D-A8CB-4C20-988E-BE3FA5F3FAACQ50239011-91B1864B-BD78-455C-92AA-A64465AC6AB3Q50462869-4F9725F9-3C59-411E-95E6-E1660622EDC4Q58434417-1C86FCC4-AF1C-4AB4-B060-8FC4EFA1A637Q59201792-5184FC43-F706-4FF7-A540-B094E2D5B785
P2860
Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors.
@en
type
label
Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors.
@en
prefLabel
Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors.
@en
P2860
P50
P356
P1476
Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors.
@en
P2093
Anna Villar-Piqué
P2860
P2888
P356
10.1186/1475-2859-11-55
P577
2012-05-03T00:00:00Z
P5875
P6179
1031531184